North America Biopsy Guidance System Market Size & Outlook

The biopsy guidance system market in North America is expected to reach a projected revenue of US$ 632.3 million by 2028. A compound annual growth rate of 5.3% is expected of North America biopsy guidance system market from 2022 to 2028.
Revenue, 2021 (US$M)
$440.3
Forecast, 2028 (US$M)
$632.3
CAGR, 2022 - 2028
5.3%
Report Coverage
North America

North America biopsy guidance system market highlights

  • The North America biopsy guidance system market generated a revenue of USD 440.3 million in 2021.
  • The market is expected to grow at a CAGR of 5.3% from 2022 to 2028.
  • In terms of segment, stereotactic guided biopsy was the largest revenue generating product in 2021.
  • Ultrasound Guided Biopsy is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, Canada is expected to register the highest CAGR from 2022 to 2028.


North America data book summary

Market revenue in 2021USD 440.3 million
Market revenue in 2028USD 632.3 million
Growth rate5.3% (CAGR from 2021 to 2028)
Largest segmentStereotactic guided biopsy
Fastest growing segmentUltrasound Guided Biopsy
Historical data covered2016 - 2020
Base year for estimation2021
Forecast period covered2022 - 2028
Quantitative unitsRevenue in USD million
Market segmentationStereotactic Guided Biopsy, Ultrasound Guided Biopsy, MRI Guided Biopsy
Key market players worldwideBecton Dickinson & Co, Hologic Inc, Utah Medical Products Inc, B. Braun, Argon Medical Devices, Boston Scientific Corp, Inrad Optics Inc, Cook Medical, Planmed


Other key industry trends

  • In terms of revenue, North America region accounted for 45.4% of the global biopsy guidance system market in 2021.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2028.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 226.9 million by 2028.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Biopsy Guidance System Market Companies

Name Profile # Employees HQ Website

North America biopsy guidance system market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopsy guidance system market will help companies and investors design strategic landscapes.


Stereotactic guided biopsy was the largest segment with a revenue share of 39.77% in 2021. Horizon Databook has segmented the North America biopsy guidance system market based on stereotactic guided biopsy, ultrasound guided biopsy, mri guided biopsy covering the revenue growth of each sub-segment from 2016 to 2028.


Reasons to subscribe to North America biopsy guidance system market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of North America biopsy guidance system market databook

  • Our clientele includes a mix of biopsy guidance system market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America biopsy guidance system market , including forecasts for subscribers. This continent databook contains high-level insights into North America biopsy guidance system market from 2016 to 2028, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

North America biopsy guidance system market size, by country, 2016-2028 (US$M)

North America Biopsy Guidance System Market Outlook Share, 2021 & 2028 (US$M)

North America biopsy guidance system market size, by country, 2016-2028 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more